The concept of an epigenetic landscape describing potential cellular fates arising from
pluripotent cells, first advanced by Conrad Waddington, has evolved in light of experiments …

Drug-tolerant persister (DTP) cell populations were originally discovered in antibiotic-
resistant bacterial biofilms. Similar populations with comparable features have since been …

Rapid advancements in materials science and nanotechnology, intertwined with oncology,
have positioned photothermal therapy (PTT) as a promising noninvasive treatment strategy …

The biological complexity of cancer represents a tremendous clinical challenge, resulting in
the frequent failure of current treatment protocols. In the rapidly evolving scenario of a …

The drug-tolerant persister (DTP) state enables cancer cells to evade cytotoxic stress from
anticancer therapy. However, the mechanisms governing DTP generation remain poorly …

In response to adverse environmental conditions, embryonic development may reversibly
cease, a process termed diapause. Recent reports connect this phenomenon with the non …

Objective Therapy-induced tumour microenvironment (TME) remodelling poses a major
hurdle for cancer cure. As the majority of patients with hepatocellular carcinoma (HCC) …

Deregulation of tumor cell metabolism is widely recognized as a “hallmark of cancer.” Many
of the selective pressures encountered by tumor cells, such as exposure to anticancer …

Chemotherapy is an important tool for the management of solid tumors including breast
cancers (BC). Its neo-adjuvant and adjuvant use is important for shrinking tumor size and …

The heterogeneity of cancer stem cells (CSCs) within tumors presents a challenge in
therapeutic targeting. To decipher the cellular plasticity that fuels phenotypic heterogeneity …